BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35668839)

  • 1. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
    Hamdy NM; Shaker FH; Zhan X; Basalious EB
    EPMA J; 2022 Jun; 13(2):261-284. PubMed ID: 35668839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
    Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
    Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis.
    Ahluwalia P; Ahluwalia M; Vaibhav K; Mondal A; Sahajpal N; Islam S; Fulzele S; Kota V; Dhandapani K; Baban B; Rojiani AM; Kolhe R
    EPMA J; 2020 Dec; 11(4):581-601. PubMed ID: 33204369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes.
    Jia W; Gong X; Ye Z; Li N; Zhan X
    EPMA J; 2023 Dec; 14(4):673-696. PubMed ID: 38094577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine.
    Zhang G; Wang Z; Song P; Zhan X
    EPMA J; 2022 Dec; 13(4):649-669. PubMed ID: 36505890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.
    Dopazo J; Maya-Miles D; García F; Lorusso N; Calleja MÁ; Pareja MJ; López-Miranda J; Rodríguez-Baño J; Padillo J; Túnez I; Romero-Gómez M
    J Pers Med; 2021 May; 11(6):. PubMed ID: 34073493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements.
    Jain N; Nagaich U; Pandey M; Chellappan DK; Dua K
    EPMA J; 2022 Dec; 13(4):561-580. PubMed ID: 36505888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical multi-omics strategies for the effective cancer management.
    Yoo BC; Kim KH; Woo SM; Myung JK
    J Proteomics; 2018 Sep; 188():97-106. PubMed ID: 28821459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-COVID-19: an insidious virus in action.
    Bratosiewicz-Wąsik J
    Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach.
    Tachalov VV; Orekhova LY; Kudryavtseva TV; Loboda ES; Pachkoriia MG; Berezkina IV; Golubnitschaja O
    EPMA J; 2021 Jun; 12(2):129-140. PubMed ID: 33897916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections.
    Dubey AK; Chaudhry SK; Singh HB; Gupta VK; Kaushik A
    Biotechnol Rep (Amst); 2022 Mar; 33():e00712. PubMed ID: 35186674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics and immune cells' profiling of COVID-19 patients for ICU admission prediction: in silico analysis and an integrated machine learning-based approach in the framework of Predictive, Preventive, and Personalized Medicine.
    Zhu K; Chen Z; Xiao Y; Lai D; Wang X; Fang X; Shu Q
    EPMA J; 2023 Mar; 14(1):101-117. PubMed ID: 36845281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients.
    Molinero M; Benítez ID; González J; Gort-Paniello C; Moncusí-Moix A; Rodríguez-Jara F; García-Hidalgo MC; Torres G; Vengoechea JJ; Gómez S; Cabo R; Caballero J; Bermejo-Martin JF; Ceccato A; Fernández-Barat L; Ferrer R; Garcia-Gasulla D; Menéndez R; Motos A; Peñuelas O; Riera J; Torres A; Barbé F; de Gonzalo-Calvo D
    Front Med (Lausanne); 2021; 8():756517. PubMed ID: 35186962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine.
    Richter K; Kellner S; Hillemacher T; Golubnitschaja O
    EPMA J; 2021 Jun; 12(2):221-241. PubMed ID: 34122671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.
    Chakravarty N; Senthilnathan T; Paiola S; Gyani P; Castillo Cario S; Urena E; Jeysankar A; Jeysankar P; Ignatius Irudayam J; Natesan Subramanian S; Lavretsky H; Joshi S; Garcia G; Ramaiah A; Arumugaswami V
    FEBS Lett; 2021 Dec; 595(23):2854-2871. PubMed ID: 34757622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude.
    Wang LY; Cui JJ; OuYang QY; Zhan Y; Wang YM; Xu XY; Yu LL; Yin H; Wang Y; Luo CH; Guo CX; Yin JY
    EPMA J; 2021 Sep; 12(3):307-324. PubMed ID: 34306260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern recognition for predictive, preventive, and personalized medicine in cancer.
    Cheng T; Zhan X
    EPMA J; 2017 Mar; 8(1):51-60. PubMed ID: 28620443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.